Elodie Vauléon Selected Research

Elodie Vauléon Research Topics

5	Glioblastoma (Glioblastoma Multiforme) 02/2023 - 03/2011
4	Neoplasms (Cancer) 01/2019 - 12/2011
3	Glioma (Gliomas) 01/2023 - 03/2011
3	Hepatocellular Carcinoma (Hepatoma) 01/2012 - 06/2011
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2020 - 12/2011
2	Head and Neck Neoplasms (Head and Neck Cancer) 05/2013 - 12/2011
2	Neoplasm Metastasis (Metastasis) 06/2012 - 05/2010
1	Squamous Cell Carcinoma of Head and Neck 12/2021
1	Neuroendocrine Carcinoma 06/2019
1	Pain (Aches) 06/2012
1	Thrombosis (Thrombus) 12/2011
1	Respiratory Insufficiency (Respiratory Failure) 06/2011
1	Interstitial Lung Diseases (Interstitial Lung Disease) 06/2011
1	Breast Neoplasms (Breast Cancer) 05/2010
1	Fibrosis (Cirrhosis) 01/2009

3	Ribonucleases (Ribonuclease)IBA 02/2023 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 12/2017 - 03/2011
2	Sorafenib (BAY 43-9006)FDA Link 01/2012 - 12/2011
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2023
1	NivolumabIBA 12/2021
1	Taxoids (Taxanes)IBA 12/2021
1	TOR Serine-Threonine KinasesIBA 01/2020
1	Angiogenesis InhibitorsIBA 01/2020
1	PlatinumIBA 01/2019
1	Antineoplastic Agents (Antineoplastics)IBA 01/2019
1	Alkylating AgentsIBA 01/2019
1	Messenger RNA (mRNA)IBA 01/2018
1	Dasatinib (BMS 354825)FDA Link 12/2017
1	Glycoproteins (Glycoprotein)IBA 12/2017
1	Histones (Histone)IBA 03/2016
1	Ethiodized Oil (Ethiodol)FDA Link 06/2011
1	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2011
1	Temozolomide (Temodar)FDA LinkGeneric 03/2011
1	neodymium pyrocatechin disulfonate (NPD)IBA 05/2010
1	Hormones (Hormone)IBA 05/2010

2	Drug Therapy (Chemotherapy) 06/2019 - 05/2010
2	Radiotherapy 06/2011 - 03/2011
1	Immunotherapy 01/2020
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 05/2013
1	Cementoplasty 06/2012
1	Combination Drug Therapy (Combination Chemotherapy) 05/2010
1	Therapeutics 05/2010
1	Chemoradiotherapy 01/2009